z-logo
open-access-imgOpen Access
Intervention in utero: Fetal gene therapy
Author(s) -
Simon N. Waddington,
Suzanne M. K. Buckley,
Charles Coutelle
Publication year - 2008
Publication title -
the biochemist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 7
eISSN - 1740-1194
pISSN - 0954-982X
DOI - 10.1042/bio03003007
Subject(s) - genetic enhancement , in utero , medicine , disease , intervention (counseling) , fetus , clinical trial , pediatrics , intensive care medicine , gene , oncology , bioinformatics , pregnancy , biology , psychiatry , genetics
Postnatal gene therapy is a reactive approach to disease treatment. The disease in question will have been diagnosed, usually after symptoms have appeared. Children with lethal immune deficiency diseases have been treated by gene therapy with a high success rate in Paris and London, and many other clinical gene therapy trials for various genetic diseases, acquired conditions and different forms of cancer are presently underway or planned in adult patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom